期刊文献+

顺铂注射液与6种质子泵抑制剂配伍溶液物理相容性考察

The Investigation on the Physical Compatibility of Admixture of CisplatinInjection with 6 Proton Pump Inhibitors
下载PDF
导出
摘要 目的考察顺铂注射液与6种质子泵抑制剂配伍溶液物理相容性。方法室温条件下,将调配的低、中、高浓度(0.06、0.09、0.12 mg·mL^(-1))顺铂分别与注射用泮托拉唑钠、艾司奥美拉唑钠、奥美拉唑钠、雷贝拉唑钠、兰索拉唑和艾普拉唑钠成品输液等体积混合;考察8 h内混合溶液的外观性状、丁达尔效应、pH值、浊度、不溶性微粒数和紫外吸光度值等指标变化。结果顺铂与泮托拉唑钠、艾司奥美拉唑、奥美拉唑钠和雷贝拉唑钠的混合溶液在8 h内外观均澄清透明,未产生丁达尔效应,pH值变化、浊度变化、不溶性微粒、紫外吸光度值变化均符合要求;低浓度顺铂与兰索拉唑混合溶液在6 h紫外吸光度值变化均不符合要求;中、高浓度顺铂与兰索拉唑混合溶液不溶性微粒数不符合要求;顺铂与艾普拉唑钠混合溶液所有指标均不符合要求。结论低浓度顺铂与兰索拉唑室温4 h内物理性状相容;低、中、高浓度顺铂与泮托拉唑钠、艾司奥美拉唑、奥美拉唑钠和雷贝拉唑钠8 h内相容;中、高浓度顺铂与兰索拉唑不相容,低、中、高浓度顺铂与艾普拉唑钠不相容。 Objective To investigate the physical compatibility of admixture of cisplatin injection with 6 proton pump inhibitors.Methods At room temperature,cisplatin solutions at low,medium and high prepared concentrations(0.06,0.09,0.12 mg·mL^(-1))were mixed with the same volume of injection solutions of pantoprazole sodium,esomeprazole sodium,omeprazole sodium,rabeprazole sodium,lansoprazole sodium and ilaprazole sodium infusion,respectively.The changes of appearance,Tyndall effect,pH value,turbidity,the number of insoluble particles and UV absorbance of the admixtures were investigated within 8 h.Results The admixtures of cisplatin with pantoprazole sodium,esomeprazole,omeprazole sodium and rabeprazole sodium were clear and transparent within 8 h,and the change of pH value,turbidity changes,insoluble particles,UV absorbance value changes met the requirements.The combination of low concentration cisplatin and lansoprazole sodium was physically compatible and stable within 8 h.The number of insoluble particles in medium did not meet the requirements when high concentration cisplatin combined with lansoprazole sodium.All the indexes did not meet the requirements when cisplatin were combined with ilaprazole sodium.Conclusions Low concentration cisplatin is compatible with Lansoprazole sodium within 4 h at room temperature.Low,medium and high concentrations of cisplatin were compatible with pantoprazole sodium,esomeprazole sodium,omeprazole sodium and rabeprazole sodium within 8 h.High concentrations of cisplatin is incompatible with lansoprazole sodium.Cisplatin with low,medium and high concentrations are incompatible with iprrazole sodium.
作者 童彤 丁海文 刘圣 唐丽琴 TONG Tong;DING Haiwen;LIU Sheng;TANG Liqin(Department of Pharmacy,Anhui Provincial Hospital,the First Affiliated Hospital of University of Science and Technology of China,Hefei 230001,China)
出处 《医药导报》 CAS 北大核心 2024年第6期965-969,共5页 Herald of Medicine
基金 安徽省教育厅科学研究项目(2022AH040184)。
关键词 顺铂注射液 质子泵抑制剂 物理相容性 丁达尔效应 不溶性微粒 浊度 紫外吸光度值 Cisplatin injection Proton pump inhibitors Physical compatibility Tyndall effect Insoluble particles Turbidity Ultraviolet absorbance value
  • 相关文献

参考文献2

二级参考文献31

  • 1纪春青.地塞米松磷酸钠注射液与盐酸昂丹司琼注射液存在配伍禁忌[J].中国药物经济学,2012(3):174.
  • 2Hesketh PJ. Chemotherapy-induced nausea and vomiting [J]. NEngl JMed, 2008,358(23) : 2 482.
  • 3Saito M, Aogi K, Sekine I, et al. Palonosetron plus dexa- methasone versus granisetron plus dexamethasone for pre- vention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase Ⅲ trial[J]. Lancet Oncol, 2009,10(2):115.
  • 4Tricco AC, Soobiah C, Blondal E, et al. Comparative sa- fety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network me- ta-analysis[J]. BMC Med, 2015,18 (13) : 142.
  • 5National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology : antiemesis[EB/OL ]. [2015- 07-01].http ://www.nccn.org/professionals.
  • 6Gan T J, Diemunsch P, Habib AS, et al. Consensus guide- lines for the management of postoperative nausea and vomiting[J]. Anesth Analg, 2014,118 (1) : 85.
  • 7Longfield V. Compatibility and stability of 5-HT3 receptor antagonists: a pharmacology review[J]. Oncol Nuts Fo- rum, 2002,29(10) : 1 469.
  • 8Hagan RL, Mallett MS, Fox JL. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in in- fusion bags and syringes for 32 days[J]. Am J Health Syst Pharm, 1996,53(12) : 1 431.
  • 9Mayron D, Gennaro AR. Stability and compatibility of granisetron hydrochloride in iv solutions and oral liquids and during simulated Y-site injection with selected drugs [J]. Am JHealth Syst Pharm, 1996,53 (3) : 294.
  • 10Pinguet F, Rouanet P, Martel P, et al. Compatibility and stability of granisetron, dexamethasone, and methylpred- nisolone in injectable solutions[J]. JPharm Sci, 1995,84 (2):267.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部